Featured Research

from universities, journals, and other organizations

Rebuilding the brain after stroke

Date:
February 13, 2014
Source:
Henry Ford Health System
Summary:
Enhancing the brain's inherent ability to rebuild itself after a stroke with molecular components of stem cells holds enormous promise for treating the leading cause of long-term disability in adults.

Enhancing the brain's inherent ability to rebuild itself after a stroke with molecular components of stem cells holds enormous promise for treating the leading cause of long-term disability in adults.

Michael Chopp, Ph.D., Scientific Director of the Henry Ford Neuroscience Institute, will present this approach to treating neurological diseases Thursday, Feb. 13, at the American Heart Association's International Stroke Conference in San Diego.

Although most stroke victims recover some ability to voluntarily use their hands and other body parts, half are left with weakness on one side of their body, and a substantial number are permanently disabled.

No treatment currently exists for improving or restoring this lost motor function in stroke patients, mainly because of mysteries about how the brain and nerves repair themselves.

But Dr. Chopp and other Henry Ford scientists may have solved some of these mysteries through experiments at the molecular level identifying and testing components of stem cells.

"Even in older people, the central nervous system is highly plastic, meaning it has a unique ability to change and rebuild itself," Dr. Chopp explains. "We have demonstrated that this plasticity can be stimulated to promote neurological recovery after a stroke."

One such therapy involves proteins that shape the developing brain, specifically a type that releases tissue plasminogen activator, or tPA, which causes axons and dendrites -- the brain's neural cables and communications network -- to rewire.

"We have shown that administering tPA in a nasal spray promotes this rewiring and significantly enhances neurological recovery," Dr. Chopp says.

Dr. Chopp will also speak at the AHA conference about other microscopic material in stem cells called exosomes that offer a "robust" treatment for stroke's crippling effects.

These blister-like microscopic "bubbles" were once were thought to carry and get rid of "old" proteins that were no longer needed by the body. However, exosomes were recently found to provide an essential form of "communication" between brain cells using "packages" sent out by stem cells with vital directions for gene regulation.

This is done through microRNA, master molecular switches that alter brain cells and promote recovery from trauma.

Dr. Chopp and his team have shown and confirmed that stem cell therapy works by firing off these "information bullets."

But they have also shown that neurological diseases can be treated with exosomes alone, separate from stem cells. "This approach may be a revolutionary way to successfully treat stroke and many other diseases," Dr. Chopp says.


Story Source:

The above story is based on materials provided by Henry Ford Health System. Note: Materials may be edited for content and length.


Cite This Page:

Henry Ford Health System. "Rebuilding the brain after stroke." ScienceDaily. ScienceDaily, 13 February 2014. <www.sciencedaily.com/releases/2014/02/140213153536.htm>.
Henry Ford Health System. (2014, February 13). Rebuilding the brain after stroke. ScienceDaily. Retrieved July 21, 2014 from www.sciencedaily.com/releases/2014/02/140213153536.htm
Henry Ford Health System. "Rebuilding the brain after stroke." ScienceDaily. www.sciencedaily.com/releases/2014/02/140213153536.htm (accessed July 21, 2014).

Share This




More Health & Medicine News

Monday, July 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins